Risant Health, Inc.: Single Audit Reports and Findings
Risant Health, Inc. filed 1 single audit between 2025 and 2025; the most recently observed auditor is KPMG LLP (2025), and the 2025 report lists 1 finding. Data as of 2026-11-06.
Data as of Nov 6, 2026 · Source: Federal Audit Clearinghouse (public data)
Single audits by year
One row per audit year as the Federal Audit Clearinghouse accepted it. The auditor named is the one observed on that filing; Risant Health, Inc. is recorded in WASHINGTON, District of Columbia under EIN 923467590, and the Clearinghouse records it as a nonprofit. Each report opens on the Clearinghouse itself; how to search the Federal Audit Clearinghouse explains the rest of the reporting package.
| Audit year | Fiscal year end | Federal expended | Threshold applied | Auditor observed | Findings | MW / SD | FAC report |
|---|---|---|---|---|---|---|---|
| 2025 | 2025-12-31 | $47,263,560 | $1,000,000 | KPMG LLP | 1 | — | 2025-12-GSAFAC-0000415357 |
When is the next single audit due?
If Risant Health, Inc. is again required to have a single audit for the fiscal year ending Dec 31, 2026, the reporting package is due to the Federal Audit Clearinghouse by Sep 30, 2027 at the latest.
Whether an audit is required depends on federal awards expended in that year (the single audit threshold). The rule, 2 CFR 200.512(a): the reporting package is due within 30 calendar days after the auditee receives the auditor's report or nine months after the end of the audit period, whichever is earlier; the date above is the nine-month date, moved to Monday when it falls on a weekend. Last verified: 2026-11-15.
Which federal programs did this organization report?
From the most recent accepted report, as listed on its schedule of expenditures of federal awards (SEFA). "Major" is the designation the auditor made under 2 CFR 200.518, not ours.
| ALN | Program | Expended | Major |
|---|---|---|---|
| 84.268 | FEDERAL DIRECT STUDENT LOANS | $20,769,373 | Yes |
| 93.837 | CARDIOVASCULAR DISEASES RESEARCH | $2,566,026 | Yes |
| 93.172 | HUMAN GENOME RESEARCH | $2,006,673 | Yes |
| 93.172 | HUMAN GENOME RESEARCH | $1,752,472 | Yes |
| 93.242 | MENTAL HEALTH RESEARCH GRANTS | $1,722,535 | Yes |
| 93.399 | CANCER CONTROL | $1,601,847 | Yes |
| 93.918 | GRANTS TO PROVIDE OUTPATIENT EARLY INTERVENTION SERVICES WITH RESPECT TO HIV DISEASE | $965,884 | No |
| 21.027 | CORONAVIRUS STATE AND LOCAL FISCAL RECOVERY FUNDS | $929,254 | No |
| 93.359 | NURSE EDUCATION, PRACTICE QUALITY AND RETENTION GRANTS | $836,585 | No |
| 93.865 | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH | $753,527 | Yes |
| 93.840 | TRANSLATION AND IMPLEMENTATION SCIENCE RESEARCH FOR HEART, LUNG, BLOOD DISEASES, AND SLEEP DISORDERS | $700,501 | Yes |
| 93.870 | MATERNAL, INFANT AND EARLY CHILDHOOD HOME VISITING GRANT | $682,066 | No |
| 93.426 | THE NATIONAL CARDIOVASCULAR HEALTH PROGRAM | $631,962 | Yes |
| 97.036 | DISASTER GRANTS - PUBLIC ASSISTANCE (PRESIDENTIALLY DECLARED DISASTERS) | $615,555 | No |
| 93.279 | DRUG USE AND ADDICTION RESEARCH PROGRAMS | $579,763 | Yes |
| 93.855 | ALLERGY AND INFECTIOUS DISEASES RESEARCH | $503,569 | Yes |
| 93.898 | CANCER PREVENTION AND CONTROL PROGRAMS FOR STATE, TERRITORIAL AND TRIBAL ORGANIZATIONS | $461,883 | No |
| 20.513 | ENHANCED MOBILITY OF SENIORS AND INDIVIDUALS WITH DISABILITIES | $456,000 | No |
| 93.810 | PAUL COVERDELL NATIONAL ACUTE STROKE PROGRAM NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION | $441,993 | No |
| 93.959 | BLOCK GRANTS FOR PREVENTION AND TREATMENT OF SUBSTANCE ABUSE | $422,179 | No |
| 93.426 | THE NATIONAL CARDIOVASCULAR HEALTH PROGRAM | $416,762 | No |
| 93.732 | MENTAL AND BEHAVIORAL HEALTH EDUCATION AND TRAINING GRANTS | $351,992 | No |
| 93.242 | MENTAL HEALTH RESEARCH GRANTS | $304,734 | Yes |
| 93.172 | HUMAN GENOME RESEARCH | $303,757 | Yes |
| 93.945 | ASSISTANCE PROGRAMS FOR CHRONIC DISEASE PREVENTION AND CONTROL | $293,096 | Yes |
What findings did the auditor report?
The reference is the auditor’s; the requirement is the Compliance Supplement category the auditor selected. The finding text itself is not reproduced here; the FAC report linked above carries it in full. What the two severity levels mean: material weakness vs significant deficiency.
| Reference | Requirement | Severity | Repeat |
|---|---|---|---|
| 2025-004 | Allowable costs / cost principles (B) | Questioned costs | No |
Form 990 and IRS registration
Form 990 "accounting fees" (Part IX line 11c) cover all accounting services reported by the organization and are not the price of an audit engagement.
Where to find the return itself, and what our Form 990 data covers: Form 990 lookup.
- Most recent return
- 990 for 2024-12
- Total revenue
- $6,730,942,360
- Total assets
- $2,972,201,383
- Accounting fees (Part IX line 11c)
- $3,908,381
- Paid preparer
- PwC US Tax LLP
- IRS object id
- 202523219349309187
- NTEE code
- E21
- Exempt under
- 501(c)(3)
- Ruling year
- 2024
- BMF release
- 2026-10-20
Read next
How we computed this
Every row comes from the Federal Audit Clearinghouse record named beside it, one report per audit year, with a resubmission superseding the filing it replaces. The auditor is the one named on that filing — it is not a statement about who audits Risant Health, Inc. now. Form 990 figures come from the IRS e-filed return named by its object id. This page exists because the organization filed at least two single audits, or one with a finding.
Cite this page
AuditRadar. “Risant Health, Inc., District of Columbia Single Audits 2025.” https://getauditradar.com/single-audits/dc/risant-health-inc-923467590/. Data as of 2026-11-06.